Resverlogix Competitors and Similar CompaniesClear all
Resverlogix's competitors and similar companies include AnGes, CRISPR Therapeutics and Lexicon Pharmaceuticals.
 Resverlogix Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. |  AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine. |  CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases. |  Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. | |
Founding Date | Founding Date 2001 | Founding Date 1999 | Founding Date 2013 | Founding Date 1995 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Calgary, CA HQ San Francisco, US | Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US | Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more |
Employees | Employees 19 | Employees 5562% decrease | Employees 393 | Employees 20216% increase |
Valuation ($) | Valuation ($) 12.9 m | Valuation ($) 78.3 m | Valuation ($) 4.2 b | Valuation ($) 737.4 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥874.1m (FY, 2025) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $49.8m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥499.9m (FY, 2025) | Cost of goods N/A | Cost of goods $274k (FY, 2025) |
Gross profit | Gross profit $50k (FY, 2025) | Gross profit ¥374.2m (FY, 2025) | Gross profit N/A | Gross profit $49.5m (FY, 2025) |
Net income | Net income ($7.8m) (FY, 2025) | Net income (¥5.1b) (FY, 2025) | Net income ($581.6m) (FY, 2025) | Net income ($50.3m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 10m | Total funding raised N/A | Total funding raised $ 127m | Total funding raised $ 244.7m |
For sources of this data, please see the company profile
View Company Profiles
AnGes
HQ
Ibaraki, JP
Employees
55
AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.
View companyCRISPR Therapeutics
HQ
Zug, CH
Employees
393
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
View companyLexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View company